New York (December 13th, 2012) - DayStar Technologies Inc. (NASDAQ: DSTI) 1.72 +0.50 (41.00%) . DayStar Technologies, Inc. has developed a thin film deposition technology for solar photovoltaic (PV) products. The Company utilizes a one-step sputter deposition process and has manufactured a commercial scales deposition tool to apply copper indium gallium diselenide (CIGS) material over area glass substrates in a continuous fashion.
In October 2012, the Company purchased of solar projects from Avatar Solar of Simi Valley, California. New additions on the Board of Directors; Former United States Secretary of Energy, former Governor of New Mexico and Nobel Prize nominee, Bill Richardson, has joined the Board of Director.
Telik, Inc. (NASDAQ:TELK) 1.76 +0.12 (7.32%). Telik, Inc. (Telik) is a clinical-stage drug development company focused on discovering and developing small molecule drugs to treat cancer. The Company discovers its product candidates using the Company’s drug discovery technology, Target-Related Affinity Profiling (TRAP). TELINTRA, its principal drug product candidate in clinical development, is a small molecule glutathione analog inhibitor of the enzyme glutathione S-transferase P1-1 (GST P1-1).
Telik, Inc. announced positive results from a Phase I multicenter dose-ranging trial of the combination of Telintra and Revlimid in patients with International Prognostic System Score (IPSS) Low to Intermediate-1 Risk non-deletion (5q) myelodysplastic syndrome (MDS).